Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Italy The Netherlands Spain
  • A study to evaluate the safety and how the body processes the combination of ibuprofen and paracetamol in children and adolescents with acute pain

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Hungary
  • A study to evaluate the effectiveness of nicotinamide in patients with Leber’s hereditary optic neuropathy who have experienced vision loss within the last 18 months

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Comparison of amoxicillin, amoxicillin-clavulanate, and placebo for the treatment of middle ear infection in children

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Finland
  • Study of the effects of Ibutamoren Mesilate in prepubertal children with growth hormone deficiency

    Not yet recruiting

    3 1
    Investigated drugs:
    France Italy Poland Romania Spain
  • Study of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia

    Not yet recruiting

    2 1 1 1
    Austria Czechia Denmark Germany Italy The Netherlands +2
  • A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Not yet recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia France Germany +9
  • A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

    Not yet recruiting

    2 1 1 1
    France
  • Study of acetylsalicylic acid and diclofenac for treating blood clots in superficial venous malformations in children aged 6 to 17 years

    Not yet recruiting

    3 1 1
    Investigated diseases:
    France
  • A study to evaluate the effectiveness of ciracigene golparvovec in children with Canavan disease

    Not yet recruiting

    2 1 1
    France